Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 29676 - 29700 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Decitabine	Approved Investigational	LRRC23	10233	upregulated	decitabine results in increased expression of LRRC23 mRNA	12p13.31	A21917
Decitabine	Approved Investigational	LST1	7940	upregulated	decitabine results in increased expression of LST1 mRNA	6p21.33	A20985
Decitabine	Approved Investigational	LYZ	4069	upregulated	decitabine results in increased expression of LYZ mRNA	12q15	A20985
Decitabine	Approved Investigational	LZTFL1	54585	downregulated	decitabine results in decreased expression of LZTFL1 mRNA	3p21.31	A21913
Decitabine	Approved Investigational	MAEL	84944	upregulated	decitabine results in increased expression of MAEL mRNA	1q24.1	A21915
Decitabine	Approved Investigational	MAGEA1	4100	upregulated	decitabine results in increased expression of MAGEA1 mRNA	Xq28	A21955 A21991 A21986 A21915
Decitabine	Approved Investigational	MAGEA10	4109	upregulated	decitabine results in increased expression of MAGEA10 mRNA	Xq28	A21915
Decitabine	Approved Investigational	MAGEA12	4111	upregulated	decitabine results in increased expression of MAGEA12 mRNA	Xq28	A21915
Decitabine	Approved Investigational	MAGEA2B	266740	upregulated	decitabine results in increased expression of MAGEA2B mRNA	Xq28	A21915
Decitabine	Approved Investigational	MAGEA3	4102	upregulated	decitabine results in increased expression of MAGEA3 mRNA	Xq28	A21955 A21986
Decitabine	Approved Investigational	MAGEA4	4103	upregulated	decitabine results in increased expression of MAGEA4 mRNA	Xq28	A21955
Decitabine	Approved Investigational	MAGEA8	4107	upregulated	decitabine results in increased expression of MAGEA8 mRNA	Xq28	A21915
Decitabine	Approved Investigational	MAGEA9	4108	upregulated	decitabine results in increased expression of MAGEA9 mRNA	Xq28	A21915
Decitabine	Approved Investigational	MAGEB2	4113	upregulated	decitabine results in increased expression of MAGEB2 mRNA	Xp21.2	A21955 A21986
Decitabine	Approved Investigational	MAL	4118	upregulated	decitabine results in increased expression of MAL mRNA	2q11.1	A21992 A21993
Decitabine	Approved Investigational	MAN1B1	11253	upregulated	decitabine results in increased expression of MAN1B1 mRNA	9q34.3	A21917
Decitabine	Approved Investigational	MAP2K1	5604	upregulated	decitabine results in increased expression of MAP2K1 mRNA	15q22.31	A21930
Decitabine	Approved Investigational	MARK1	4139	upregulated	decitabine results in increased expression of MARK1 mRNA	1q41	A21919
Decitabine	Approved Investigational	MASP1	5648	downregulated	decitabine results in decreased expression of MASP1 mRNA	3q27.3	A20985
Decitabine	Approved Investigational	MBD1	4152	upregulated	decitabine results in increased expression of MBD1 mRNA	18q21.1	A21964
Decitabine	Approved Investigational	MBD3	53615	upregulated	decitabine results in increased expression of MBD3 mRNA	19p13	A21917
Decitabine	Approved Investigational	MBD3L2	125997	upregulated	decitabine results in increased expression of MBD3L2 mRNA	19p13.2	A21919
Decitabine	Approved Investigational	MECR	51102	upregulated	decitabine results in increased expression of MECR mRNA	1p35.3	A21917
Decitabine	Approved Investigational	MEF2C	4208	upregulated	decitabine results in increased expression of MEF2C mRNA	5q14.3	A21912
Decitabine	Approved Investigational	MET	4233	downregulated	decitabine results in decreased expression of MET mRNA	7q31	A21913

Displaying entries 29676 - 29700 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability